Christine Farrell
Director Financiero/CFO en ODYSSEY HEALTH, INC. .
Fortuna: 50 772 $ al 30/04/2024
Perfil
Christine M.
Farrell is currently the Chief Financial Officer & Secretary at Odyssey Health, Inc. She previously worked as the Vice President-Finance & Administration at Bioject Medical Technologies, Inc. from 1997 to 2014.
She completed her undergraduate degree at the University of Washington and holds an MBA from Willamette University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ODYSSEY HEALTH, INC.
1.42% | 29/12/2023 | 1 372 222 ( 1.42% ) | 50 772 $ | 30/04/2024 |
Cargos activos de Christine Farrell
| Empresas | Cargo | Inicio |
|---|---|---|
| ODYSSEY HEALTH, INC. | Director Financiero/CFO | 21/01/2021 |
Antiguos cargos conocidos de Christine Farrell.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOJECT MEDICAL TECHNOLOGIES INC. | Director Financiero/CFO | 01/07/2014 |
Formación de Christine Farrell.
| University of Washington | Undergraduate Degree |
| Willamette University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ODYSSEY HEALTH, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR. | Health Technology |
- Bolsa de valores
- Insiders
- Christine Farrell
